PCSK9 and familial hyperaldosteronism: FH, caused by pathogenic variants in LDLR, PCSK9, and APOB, is characterized by elevated plasma low-density lipoprotein cholesterol (LDL-C) levels, which leads to risks for cardiovascular disease and premature mortality (Youngblom et al., 2016).